Management Team - Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
15
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Management Team

World-class scientific team, management team, and advisory board

Segra management consists of an extremely well-rounded group of academics, growers/breeders, sales and marketing specialists, and financial executives. The company’s Advisory Board includes leading experts in the areas of clinical research, plant science, analytical chemistry, marketing, business, and engineering.

Jamie Blundell

CEO

Mr. Blundell is the CEO of Segra International.  He brings over 25 years of experience in senior leadership roles with a broad range of B2B experience and operational expertise in rapidly growing companies in the cannabis, digital media and manufacturing industries. He’s had extensive dealings with M&A, private equity firms, capital markets and large corporate divestitures and brings a focused and disciplined approach to guiding Segra’s growth.

Zhe Choo

CPA, CA, EVP Finance

Ms. Choo joined Segra in July 2018 with 13 years of progressive public accounting and finance experience. Ms. Choo began her career in the Audit and Assurance Group at PricewaterhouseCoopers LLP and then went on to become a Senior Manager at Ernst & Young LLP where she provided accounting services and advice to numerous clients on various complex accounting transactions. Prior to joining Segra, Ms. Choo worked at a space technology company and was involved in a US$2.4 billion acquisition and integrating the acquired entity.

Dr. Sma Zobayed

Ph.D., Chief Tissue Culture Officer

Dr. Zobayed is a leading specialist in tissue culturing with extensive international experience. Dr. Zobayed holds two patents relating to tissue culturing and has published over 50 scientific papers related to his research in the field. He holds a Ph.D. in Plant Tissue Culture, from the Department of Biological Sciences, University of Hull (UK), and has won awards for his tissue culture work from the scientific community. He is a member in good standing with the International Society of Arboriculture, International Association for Plant Tissue Culture and the International Society for Horticultural Sciences.

Ian Davidson

Director of Global Business Development

Ian Davidson is a farmer, entrepreneur, and agricultural visionary who has dedicated his entire professional career to building new companies focused on sustainable agricultural production, marketing, and distribution. Ian’s experience in the cannabis space spans more than 15 years, having founded two successful cannabis-focused companies in California. In 2007, Ian founded Biologic Crop Solutions LLC, a landmark wholesale farm supply company providing products and services to over 500 commercial cannabis operations globally. Under Ian’s leadership BCS has established itself as an industry authority on best practices and sustainability for cannabis cultivation. In 2015, Ian founded the agricultural consulting company Davidson Organics, where he developed over 600,000 square feet of high-tech greenhouse cannabis production in California. From 2012-2015, Ian served as the Agronomy Manager for Biological Capital LLC, located on the Hawaiian island of Maui, where he managed agricultural operations at the historic 4000acre Hana Ranch and OW Farm (Oprah Winfrey.) 

Carson Otto

Director of Sales

Carson Otto co-leads the global business development efforts at Segra. He obtained his BESc in biochemical engineering at the University of Western Ontario where he researched and designed award winning industrial-scale cannabinoid extraction processes. Further pursuing the cannabis industry, Carson graduated from the inaugural class of Commercial Cannabis Production at Niagara College gaining extensive knowledge of the cannabis sector through internships at Canadian Licensed Producers.


Mitch Galton

Director of Sales

Mitch Galton is an experienced sales professional with a background in agricultural technology and commercial cannabis production. As one of the first sales resources at Fluence Bioengineering, Mitch has spent his career collaborating with licensed producers on the implementation and operation of large scale horticultural lighting systems. Through this work Mitch has gained an in depth understanding of seed to sale cannabis production across North America with a particular focus on the Canadian medical and recreational markets. 


Dr. John Brunstein

Chief Scientific Officer

Dr. Brunstein obtained his Ph.D. in Biochemistry from the University of British Columbia in 1997, working on the molecular biology of viruses. Since then he has has worked with credible organizations including UBC as a Clinical Assistant Professor and later became the Chief Scientific Officer at the Centre for Translational and Applied Genomics. Dr. Brunstein has primarily worked through the company he founded, PathoID, as a consultant on biotechnology, molecular biology, and clinically related topics including clinical trials, assay validation methods, and quality systems in regulated industries for industrial and clinical sites in the US, Canada, and China. Dr. Brunstein has a broad exposure to biochemical analytical and molecular methods, quality systems, application of ISO/Health Canada/FDA and similar regulatory frameworks, and project management. His recognitions include the UBC Department of Pathology 2010 Faculty Award for Excellence in Research and Discovery, and he has an extensive publication record including a widely read monthly serialized article “The Primer” on aspects of clinical molecular diagnostics, now in its third year of publication in Medical Laboratory Observer.

Dr. Kevin She

BA, MSc., Ph.D., Quality Assurance, Senior Scientist, Head of Security

Dr. She has a diverse background including industrial microbiology for the discovery of novel antibiotics, extensive expertise in mammalian tissue and cell culture, and industrial experience in writing, implementing, and training SOPs for the production, quality control, test validation, and stability testing of products intended for use in the clinical setting. During his time with Segra, Dr. She has been involved in ensuring compliance with multiple regulatory authorities, and in designing Segra facilities.

Christine Thomson

Corporate Secretary

Ms. Thomson has 20 years of experience in the securities market including 12 years direct experience acting as an officer and or director providing corporate secretary services to listed companies. This experience includes working with highly active and successful companies listed on the TSX, TSX.V, NYSE and the Alternative Investment Market of the London Stock Exchange.

Ying Ng

Molecular Biology Lab Manager

Ms. Ng obtained her B.Sc. in Molecular Biology and Biochemistry from Simon Fraser University, followed by the Registered Technologist (CSMLS) program in Clinical Genetics from the British Columbia Institute of Technology. Working at BC Provincial Health Services Authority (PHSA) for over 12 years, she started as a clinical molecular and cytogenetics technologist. In 2011, she obtained formal certification in biobanking and led the biobanking efforts for the BC Cancer Agency and Vancouver General Hospital. In 2013 she completed her M.A. in Leadership from Trinity Western University. Most recently prior to joining Segra, her role in PHSA was as a lab manager where she oversaw facility planning of laboratory space, acquired capital equipment, and ensured proper resourcing of multiple projects.

Prabhleen Kaur

Vice-President of Production

Ms. Kaur is a highly technical and efficient tissue culture specialist who has studied under the tutelage of Dr. Zobayed for the past five years. She received her Diploma in Production Horticulture in 2015 from Kwantlen Polytechnic University. From there she achieved her Certification on Photoautotrophic Tissue Culture from the Faculty of Horticulture at Chiba University in Japan and Certification on Micropropagation Techniques from Nerang MDC in Australia. She began her career in 2011 as a Quality Control Technician at Lally Farms in Abbotsford, BC, and was then hired at JRT Nurseries, in Aldergrove, BC, as the Plant Tissue Culture Supervisor. She has held positions of increasing responsibility at JRT Nurseries, where she most recently held the position of Assistant Manager for the Tissue Culture Labs in Washington State and BC, that have a maximum output of 12 million plants a year for over 500 different plant species.

Vasyl Zaiets

PMP, MSc., Project Manager

Mr. Zaiets joined Segra in August of 2018 with extensive project management experience. He earned his Master’s Degree in Nuclear Engineering from the National Technical University of Ukraine, obtained his Business Management Diploma from BCIT, and currently holds a PMP designation. Prior to joining Segra, he was with ENCO involved in managing large-scale international projects related to nuclear safety and radioactive waste management.

Kane D’Arcy Cusack

BA, MSc., Agronomy Supervisor

Mr. D’Arcy Cusack is a plant specialist with a diverse academic background in crop pathology, genetics, and ecology. He completed his bachelor’s in Plant Sciences at Trinity College in Dublin, Ireland, and his master’s degree at the School of Agriculture and Food Science at University College Dublin. His previous academic research includes elucidating genetic markers associated with resistance in oats to the fungal pathogen, Fusarium langsethiae, through the cultivation, inoculation, and analysis of a diverse panel of heritage and cultivated oat varieties. In December of 2019, Mr. D’Arcy Cusack joined the Segra team where he currently oversees all aspects of ex vitro plantlet production and research in collaboration with Segra’s clients and academic affiliations.